Creating an immune-privileged site using retinal progenitor cells and biodegradable polymers

Stem Cells

Volumn 25, Issue 6, 2007, Pages 1552-1559

  Tat, Fong Ng ^a   Lavik, Erin ^b   Keino, Hiroshi ^a   Taylor, Andrew W ^a   Langer, Robert S ^c   Young, Michael J ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b Yale University   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Immunology; Polymer; Stem cells; Transplantation

Indexed keywords

FAS LIGAND; INDOLEAMINE 2,3 DIOXYGENASE; OVALBUMIN; POLYMER; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; BIODEGRADABLE IMPLANT; CELL DIFFERENTIATION; CELL SURVIVAL; COMPOSITE GRAFT; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; GRAFT SURVIVAL; MOUSE; NONHUMAN; RETINA CELL; STEM CELL;

ABSORBABLE IMPLANTS; ANIMALS; BIOCOMPATIBLE MATERIALS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CELLS, CULTURED; GLYCOLATES; HYPERSENSITIVITY, DELAYED; INTERFERON TYPE II; KIDNEY; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MODELS, BIOLOGICAL; POLYMERS; RETINA; STEM CELLS; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HETEROTOPIC; TRANSPLANTATION, HOMOLOGOUS;

MURINAE;

EID: 34547125566     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2006-0780     Document Type: Article

References (26)

1. Streilein JW, Niederkorn JY, Shadduck JA. Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens. J Exp Med 1980;152:1121-1125.
2. Bellgrau D, Gold D, Selawry H et al. A role for CD95 ligand in preventing graft rejection. Nature 1995;377:630-632.
3. Ng TF, Osawa H, Hori J et al. Allogeneic neonatal neuronal retina grafts display partial immune privilege in the subcapsular space of the kidney. J Immunol 2002;169:5601-5606.
4. Hori J, Ng TF, Shatos M et al. Neural progenitor cells lack immunogenicity and resist destruction as allografts. STEM CELLS 2003;21:405-416.
5. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815-1822.
6. Pluchino S, Zanotti L, Rossi B et al. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 2005;436:266-271.
7. Warfvinge K, Kiilgaard JF, Lavik EB et al. Retinal progenitor cell xenografts to the pig retina: Morphologic integration and cytochemical differentiation. Arch Ophthalmol 2005;123:1385-1393.
8. Klassen HJ, Ng TF, Kurimoto Y et al. Multipotent retinal progenitors express developmental markers, differentiate into retinal neurons, and preserve light-mediated behavior. Invest Ophthalmol Vis Sci 2004;45:4167-4173.
9. Tomita M, Lavik E, Klassen H et al. Biodegradable polymer composite grafts promote the survival and differentiation of retinal progenitor cells. STEM CELLS 2005;23:1579-1588.
10. Klassen H, Ziaeian B, Kirov, II et al. Isolation of retinal progenitor cells from post-mortem human tissue and comparison with autologous brain progenitors. J Neurosci Res 2004;77:334-343.
11. McLaren FH, Svendsen CN, Van der Meide P et al. Analysis of neural stem cells by flow cytometry: Cellular differentiation modifies patterns of MHC expression. J Neuroimmunol 2001;112:35-46.
12. Modo M, Mellodew K, Rezaie P. In vitro expression of major histocompatibility class I and class II antigens by conditionally immortalized murine neural stem cells. Neurosci Lett 2003;337:85-88.
13. Klassen HJ, Imfeld KL, Kirov, II et al. Expression of cytokines by multipotent neural progenitor cells. Cytokine 2003;22:101-106.
14. Namba K, Kitaichi N, Nishida T et al. Induction of regulatory T cells by the immunomodulating cytokines alpha-melanocyte-stimulating hormone and transforming growth factor-beta2. J Leukoc Biol 2002;72:946-952.
15. Gregory MS, Repp AC, Holhbaum AM et al. Membrane Fas ligand activates innate immunity and terminates ocular immune privilege. J Immunol 2002;169:2727-2735.
16. Streilein JW, Ksander BR, Taylor AW. Immune deviation in relation to ocular immune privilege. J Immunol 1997;158:3557-3560.
17. Munn DH, Zhou M, Attwood JT et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998;281:1191-1193.
18. Malina HZ, Martin XD. Indoleamine 2,3-dioxygenase: Antioxidant enzyme in the human eye. Graefes Arch Clin Exp Ophthalmol 1996;234:457-462.
19. Teng YD, Lavik EB, Qu X et al. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci U S A 2002;99:3024-3029.
20. Mammolenti M, Gajavelli S, Tsoulfas P et al. Absence of major histocompatibility complex class I on neural stem cells does not permit natural killer cell killing and prevents recognition by alloreactive cytotoxic T lymphocytes in vitro. STEM CELLS 2004;22:1101-1110.
21. Meisel R, Zibert A, Laryea M et al. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004;103:4619-4621.
22. Terness P, Bauer TM, Rose L et al. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: Mediation of suppression by tryptophan metabolites. J Exp Med 2002;196:447-457.
23. Osawa H, Maruyama K, Streilein JW. CD95 ligand expression on corneal epithelium and endothelium influences the fates of orthotopic and heterotopic corneal allografts in mice. Invest Ophthalmol Vis Sci 2004;45:1908-1915.
24. Stuart PM, Griffith TS, Usui N et al. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest 1997;99:396-402.
25. Taylor A. A review of the influence of aqueous humor on immunity. Ocul Immunol Inflamm 2003;11:231-241.
26. Levenberg S, Huang NF, Lavik E et al. Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc Natl Acad Sci U S A 2003;100:12741-12746.